Подписаться
Hanaa Nafady-Hego
Hanaa Nafady-Hego
Professor of Microbiology and immunology, faculty of medicine, Assiut University
Подтвержден адрес электронной почты в домене aun.edu.eg
Название
Процитировано
Процитировано
Год
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination
AA Butt, H Nafady-Hego, H Chemaitelly, AB Abou-Samra, A Al Khal, ...
International Journal of Infectious Diseases 110, 353-358, 2021
972021
Herd immunity against severe acute respiratory syndrome coronavirus 2 infection in 10 communities, Qatar
A Jeremijenko, H Chemaitelly, HH Ayoub, M Alishaq, AB Abou-Samra, ...
Emerging infectious diseases 27 (5), 1343, 2021
772021
Factors affecting operational tolerance after pediatric living‐donor liver transplantation: impact of early post‐transplant events and HLA match
H Ohe, K Waki, M Yoshitomi, T Morimoto, H Nafady‐Hego, N Satoda, Y Li, ...
Transplant International 25 (1), 97-106, 2012
522012
The generation of donor-specific CD4+ CD25++ CD45RA+ naive regulatory T cells in operationally tolerant patients after pediatric living-donor liver transplantation
H Nafady-Hego, Y Li, H Ohe, X Zhao, N Satoda, S Sakaguchi, K Wood, ...
Transplantation 90 (12), 1547-1555, 2010
502010
Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11‐year single‐center experience
H Nafady‐Hego, H Elgendy, WE Moghazy, K Fukuda, S Uemoto
Liver Transplantation 17 (8), 976-984, 2011
482011
Intragraft Vδ1 γδ T cells with a unique T-cell receptor are closely associated with pediatric semiallogeneic liver transplant tolerance
X Zhao, Y Li, H Ohe, H Nafady-Hego, S Uemoto, GA Bishop, T Koshiba
Transplantation 95 (1), 192-202, 2013
462013
Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers
M Alishaq, H Nafady-Hego, A Jeremijenko, JA Al Ajmi, M Elgendy, ...
PLoS One 16 (10), e0258820, 2021
452021
Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab
A Rashad, S Mousa, H Nafady-Hego, A Nafady, H Elgendy
Scientific Reports 11 (1), 8816, 2021
322021
Increased frequency and FOXP3 expression of human CD8+ CD25High+ T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma
AM Zahran, H Nafady-Hego, SG Mansor, WA Abbas, MO Abdel-Malek, ...
Human immunology 80 (7), 510-516, 2019
322019
Therapeutic efficacy of macrolides in management of patients with mild COVID-19
A Rashad, A Nafady, MH Hassan, H Mansour, U Taya, SES Bazeed, ...
Scientific reports 11 (1), 16361, 2021
312021
Awareness of contact lens care among college students in Saudi Arabia
AY Bamahfouz, H Nafady-Hego, S Jouhargy, MA Qadir, WNJ Qutub, ...
Int J Scient Study 4 (1), 90-96, 2016
252016
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study
A Jeremijenko, H Chemaitelly, HH Ayoub, MAH Abdulla, AB Abou-Samra, ...
MedRxiv, 2020.09. 24.20200543, 2020
212020
Oxidative stress in pediatric patients with β thalassemia major
A Nafady, SS Ali, HMA El Masry, KA Baseer, HM Qubaisy, SG Mahmoud, ...
The Egyptian Journal of Haematology 42 (3), 123-127, 2017
182017
SARS-CoV-2 infection in mortuary and cemetery workers
M Alishaq, A Jeremijenko, H Nafady-Hego, JA Al Ajmi, M Elgendy, ...
International Journal of Infectious Diseases 105, 621-625, 2021
162021
Minimal but essential doses of immunosuppression: a more realistic approach to improve long-term outcomes for pediatric living-donor liver transplantation
H Ohe, Y Li, H Nafady-Hego, W Kayo, S Sakaguchi, K Wood, R Calne, ...
Transplantation 91 (7), 808-810, 2011
152011
Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation
H Nafady-Hego, Y Li, H Ohe, H Elgendy, X Zhao, S Sakaguchi, GA Bishop, ...
Transplant Immunology 36, 1-8, 2016
132016
Prognostic role of monocytic myeloid-derived suppressor cells in advanced non-small-cell lung cancer: relation to different hematologic indices
AM Zahran, HF Hetta, ZAM Zahran, A Rashad, A Rayan, DO Mohamed, ...
Journal of immunology research 2021, 2021
112021
Prevalence and risk factors for SARS-CoV-2 infection and seroprevalence among clinical and non-clinical staff in a national healthcare system
M Alishaq, A Jeremijenko, Z Al-Kanaani, H Nafady-Hego, DH Jboor, ...
PLoS One 16 (9), e0257845, 2021
102021
Peripheral lymphocytes analyses in children with chronic hepatitis C virus infection
A Nafady, H Nafady‐Hego, NM Abdelwahab, RHN Eltellawy, ...
European Journal of Clinical Investigation 48 (10), e13004, 2018
82018
Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
H Elgendy, H Nafady-Hego, HM Abd Elmoneim, T Youssef, A Alzahrani
Indian Journal of Anaesthesia 63 (10), 805-813, 2019
72019
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20